Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Iberogast and Iberogast N on intestinal gas transit and tolerance
2019-003976-38Phase 4Completed
- Sponsor
- Germans Trias i Pujol Research Institute
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Iberogast and STW 5-II in irritable bowel syndrome (IBS) and functional dyspepsia (FD) (3 arms), sponsored by Germans Trias i Pujol Research Institute. Started Jan 2020; status: completed.
02
Drugs
IberogastSTW 5-II
03
Conditions
irritable bowel syndrome (IBS)functional dyspepsia (FD)
Beyond the preview
Go deeper on 2019-003976-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003976-38.